Tilray Brands Inc. (NASDAQ: $TLRY) is a leading global producer and supplier of cannabis products for adults, medical cannabis products, and hemp products based in Leamington, Ontario. It operates in Australia, the US, Canada, and Europe.
In a groundbreaking achievement, Tilray Brands secured approval for the first medical cannabis extract in Portugal, marking a significant stride in the medical cannabis industry. This landmark achievement solidifies Tilray’s position as a pioneer in the field and paves the way for expanded therapeutic options and enhanced patient care within the country.
The newly approved product, Tilray Oral Solution THC 5 CBD 20, represents a significant step forward in medical cannabis accessibility. The company’s Head of International Business and CSO, Denise Faltischek, hailed the approval as a “monumental step forward for patient care in Portugal.”
Expanding Horizons for Patient Care
The approval, granted on March 11, 2024, is a testament to Tilray’s relentless pursuit of expanding regulated and safe access to medical cannabis for patients in need. With the newly approved extract set to launch in late spring, patients across Portugal with specified medical conditions will soon have access to novel therapeutic options.
The approved extract is poised to significantly impact several critical areas of patient care, further reinforcing Tilray’s commitment to advancing the field of medical cannabis and driving innovation that improves lives.
Diversifying the Cannabis Beverage Landscape
Complementing its medical cannabis endeavors, Tilray Brands has also made strides in the cannabis beverage market. On March 13, 2024, the company introduced its latest offering under the MOLLO® brand. This new lineup of cannabis-infused non-alcoholic seltzers boasts a unique characteristic: high cannabigerol (CBG) minor cannabinoid content, evoking the allure of consumer-favorite low-alcohol beverages.
Building upon the success of its original lineup of refreshing non-alcoholic lagers, including Mollo 5 and Mollo 10, as well as the fan-favorite ORCHARD CHILL’R™ cannabis-infused apple cider beverage, Mollo continues to blaze new trails in the cannabis beverage market.
CBG-Infused Seltzers: Mollo’s Unique Formula
As consumers increasingly integrate cannabis beverages into their consumption rituals and occasions, the demand for lower sugar content and new flavor options has grown, making sessionability a desirable trait. With seltzers now representing 25% of trending cannabis beverage unit sales and continuing to grow year after year, Mollo’s new release offers a fresh spin on seltzers and an elevated way to consume.
Unlike traditional 1:1 formulations, Tilray Brands’ Mollo Seltzers offer a unique ratio of 2 parts CBG to 1 part THC. Each seltzer contains 10mg of high-purity THC and nano-emulsified cannabinoids, ensuring no cannabis aftertaste. It has zero sugar, zero calories, three natural flavors, and a 20mg CBG boost, all in a sleek 355 mL can.
A Holistic Approach to Health and Wellness
Tilray Brands’ subsidiary, Manitoba Harvest Hemp Foods, a prominent figure in hemp-based foods, presented innovative breakfast solutions at the Natural Products Expo West 2024. Among their offerings were the Superseed Oatmeal varieties, including Original, Apple & Cinnamon, and Maple & Brown Sugar, each packed with 10g of protein, 4g of fiber, and 9g of Omegas 3 & 6 per serving.
Additionally, they unveiled their Organic Bioactive Fiber, boasting 6g of fiber per serving to support healthy digestion and gut health.
These innovations aimed to provide sustainable and nutrient-rich options for consumers seeking long-lasting energy sources. The company’s presence at the expo showcased its commitment to pioneering regenerative agriculture practices in hemp and promoting holistic health through its products.
Tilray Brands ($TLRY) Stock Performance
Today, March 18, 2024, TLRY stock soared by 12.72% to $1.95 from $1.73, reflecting investors’ confidence in the company’s expansion into new markets and the potential for growth within the medical cannabis sector.
Despite a volatile 52-week period marked by a -30.24% change, Tilray Brand’s recent success has sparked renewed interest among investors. The S&P500 index witnessed a 29.50% change over the same period. With a 52-week high of $3.40 and a low of $1.50, TLRY stock holds a 50-day moving average of $1.8722. The average volume of 16.03 million shares traded over 10 days and a market capitalization of $1.454 billion further underscore the company’s market presence.
TLRY Stock – A Promising Opportunity
Tilray Brands’ recent achievements in Portugal and innovative product offerings have solidified its position as a trailblazer in the medical cannabis industry. With investor confidence soaring and a comprehensive strategy encompassing medical cannabis, cannabis-infused beverages, and hemp-based foods, Tilray Brands is poised to capitalize on the immense growth potential within these burgeoning markets.
Given the company’s unwavering commitment to research, accessibility, and holistic well-being, TLRY stock emerges as a compelling buy for investors seeking exposure to the dynamic and ever-evolving cannabis industry.
Click Here for Updates on Tilray Brands – It’s 100% FREE to Sign Up for Text Message Notifications!
Disclaimer: This website provides information about cryptocurrency and stock market investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for educational and informational purposes only. The owner of this website is not a registered investment advisor and does not offer investment advice. You, the reader / viewer, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment.
